Studies on Low Dose Oral Contraceptives: Plasma Hormone Changes in Relation to Deliberate Pill ('Microgynon 30') Omission
Overview
Affiliations
U.S. Selected Practice Recommendations for Contraceptive Use, 2024.
Curtis K, Nguyen A, Tepper N, Zapata L, Snyder E, Hatfield-Timajchy K MMWR Recomm Rep. 2024; 73(3):1-77.
PMID: 39106301 PMC: 11340200. DOI: 10.15585/mmwr.rr7303a1.
Zapata L, Steenland M, Brahmi D, Marchbanks P, Curtis K Contraception. 2012; 87(5):685-700.
PMID: 23083527 PMC: 4322904. DOI: 10.1016/j.contraception.2012.08.035.
Modeling and simulation of adherence: approaches and applications in therapeutics.
Kenna L, Labbe L, Barrett J, Pfister M AAPS J. 2005; 7(2):E390-407.
PMID: 16353919 PMC: 2750977. DOI: 10.1208/aapsj070240.
Ovarian follicular development during the use of oral contraception: a review.
Baerwald A, Pierson R J Obstet Gynaecol Can. 2004; 26(1):19-24.
PMID: 14715122 PMC: 2891973. DOI: 10.1016/s1701-2163(16)30692-2.
Role of patient compliance in clinical pharmacokinetics. A review of recent research.
Urquhart J Clin Pharmacokinet. 1994; 27(3):202-15.
PMID: 7988102 DOI: 10.2165/00003088-199427030-00004.